Medicus Pharma Ltd (MDCX): Next-Year EPS Estimate 30.65%
As of 2026-05-28, Medicus Pharma Ltd (MDCX) has a next-year EPS growth estimate of 30.65%.
On 2026-05-21, analyst consensus for MDCX's next-year EPS growth shifted from 30.20% to 30.65% — a positive change of 0.45 percentage points. The revised estimate has been sustained across 6 subsequent trading sessions. Current-year growth is projected at 79.41%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- EPS growth next year
- 30.65%
- EPS growth this year
- 79.41%
- EPS next quarter (est)
- -$0.16
- Last price
- $0.33
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-28 | 30.65% | 79.41% | -$0.16 | $0.33 |
| 2026-05-27 | 30.65% | 79.41% | -$0.16 | $0.31 |
| 2026-05-26 | 30.65% | 79.41% | -$0.16 | $0.29 |
| 2026-05-25 | 30.65% | 79.41% | -$0.16 | $0.30 |
| 2026-05-24 | 30.65% | 79.41% | -$0.16 | $0.30 |
| 2026-05-21 | 30.65% | 79.41% | -$0.16 | $0.29 |
| 2026-05-20 | 30.20% | 78.49% | -$0.17 | $0.29 |
| 2026-05-19 | 30.20% | 78.49% | -$0.17 | $0.28 |
| 2026-05-18 | 30.20% | 78.49% | -$0.17 | $0.29 |
| 2026-05-17 | 30.20% | 78.49% | -$0.17 | $0.30 |
| 2026-05-14 | 29.60% | 78.68% | -$0.19 | $0.34 |
| 2026-05-13 | 29.60% | 78.68% | -$0.19 | $0.32 |
| 2026-05-12 | 29.60% | 78.68% | -$0.19 | $0.32 |
| 2026-05-11 | 29.60% | 78.68% | -$0.19 | $0.33 |
| 2026-05-10 | 29.60% | 78.68% | -$0.19 | $0.34 |
| 2026-05-07 | 29.60% | 78.68% | -$0.19 | $0.31 |
| 2026-05-06 | 29.60% | 78.68% | -$0.19 | $0.33 |
| 2026-05-05 | 29.49% | 78.65% | -$0.19 | $0.28 |
| 2026-05-04 | 29.49% | 78.65% | -$0.19 | $0.29 |
| 2026-05-03 | 29.49% | 78.65% | -$0.19 | $0.29 |
| 2026-04-30 | 29.49% | 78.65% | -$0.19 | $0.28 |
| 2026-04-29 | 29.49% | 78.65% | -$0.19 | $0.29 |
| 2026-04-28 | 29.49% | 78.65% | -$0.19 | $0.30 |
| 2026-04-27 | 29.49% | 78.65% | -$0.19 | $0.30 |
| 2026-04-26 | 29.49% | 78.65% | -$0.19 | $0.31 |
| 2026-04-24 | 29.49% | 78.65% | -$0.19 | $0.31 |
| 2026-03-27 | 72.18% | N/A | N/A | $0.45 |
| 2026-03-26 | 72.18% | N/A | N/A | $0.47 |
| 2026-03-26 | 72.18% | N/A | N/A | $0.47 |
| 2026-03-26 | 72.18% | N/A | N/A | $0.47 |
Recent News
- Medicus Pharma highlights positive dose-response in updated skin cancer trial resultsProactive
- Nasdaq and S&P surge to new records on Iran deal hopes, AMD and Disney gainsProactive
- Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-ResponseGlobeNewswire
- Medicus Pharma advances Skinject in rare disease ICYMIProactive
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Medicus Pharma Ltd's next-year EPS growth estimate?▾
As of 2026-05-28, Medicus Pharma Ltd (MDCX) has a next-year EPS growth estimate of 30.65%, based on analyst consensus.
When was the latest EPS estimate revision for MDCX?▾
The most recent revision occurred on 2026-05-21, when analysts adjusted the next-year EPS growth estimate from 30.20% to 30.65%.
What sector and industry does Medicus Pharma Ltd belong to?▾
Medicus Pharma Ltd operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MDCX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Medicus Pharma Ltd (MDCX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports